{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T06:02:43Z","timestamp":1783749763532,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.xphs.2023.09.026","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T07:27:59Z","timestamp":1699428479000},"page":"961-973","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Ocular Mucoadhesive and Biodegradable Sponge-Like Inserts for the Sustained and Controlled Delivery of Voriconazole; Preparation, D-optimal Factorial Optimization and in-vivo Evaluation"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9289-4475","authenticated-orcid":false,"given":"Mayada","family":"Said","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Elsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Aboelwafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed H.","family":"Elshafeey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.xphs.2023.09.026_bib0001","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.iccn.2005.02.006","article-title":"Voriconazole in the treatment of invasive fungal infections","volume":"21","author":"Keady","year":"2005","journal-title":"Intensive Crit Care Nurs"},{"issue":"1","key":"10.1016\/j.xphs.2023.09.026_bib0002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.drup.2003.12.002","article-title":"Immunotherapy for invasive fungal infections: from bench to bedside","volume":"7","author":"Pappas","year":"2004","journal-title":"Drug Resist Updat"},{"issue":"5","key":"10.1016\/j.xphs.2023.09.026_bib0003","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ijantimicag.2009.12.021","article-title":"Monitoring plasma voriconazole levels following intravenous administration in critically ill patients: an observational study","volume":"35","author":"Myrianthefs","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.xphs.2023.09.026_bib0004","doi-asserted-by":"crossref","first-page":"880","DOI":"10.5455\/2320-6012.ijrms20150411","article-title":"A retrospective study of fungal corneal ulcer from the western part of Uttar Pradesh","volume":"3","author":"Singh","year":"2015","journal-title":"Int J Res Med Sci"},{"issue":"12","key":"10.1016\/j.xphs.2023.09.026_bib0005","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1080\/03639045.2016.1185437","article-title":"Solid lipid nanoparticle: an efficient carrier for improved ocular permeation of voriconazole","volume":"42","author":"Kumar","year":"2016","journal-title":"Drug Dev Ind Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2023.09.026_bib0006","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ajo.2003.11.078","article-title":"In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens","volume":"137","author":"Marangon","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xphs.2023.09.026_bib0007","first-page":"391","article-title":"Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis","author":"Al-Badriyeh","year":"2010","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.xphs.2023.09.026_bib0008","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.clae.2011.06.004","article-title":"Role of voriconazole in combined acanthamoeba and fungal corneal ulcer","volume":"34","author":"Gupta","year":"2011","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.xphs.2023.09.026_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2020.102075","article-title":"Central composite optimization of ocular mucoadhesive cubosomes for enhanced bioavailability and controlled delivery of voriconazole","volume":"61","author":"Said","year":"2021","journal-title":"J Drug Delivery Sci Technol"},{"issue":"2","key":"10.1016\/j.xphs.2023.09.026_bib0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/1567201810666131224105205","article-title":"Design and evaluation of HP-\u03b2-CD based voriconazole formulations for ocular drug delivery","volume":"11","author":"Pahuja","year":"2014","journal-title":"Curr Drug Delivery"},{"key":"10.1016\/j.xphs.2023.09.026_bib0011","first-page":"2013","article-title":"Hp\u2013CD-voriconazole in situ gelling system for ocular drug delivery: in vitro, stability, and antifungal activities assessment","author":"Pawar","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.xphs.2023.09.026_bib0012","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.colsurfb.2015.06.036","article-title":"Liposomal voriconazole (VOR) formulation for improved ocular delivery","volume":"133","author":"de S\u00e1","year":"2015","journal-title":"Colloids Surf B"},{"issue":"1-2","key":"10.1016\/j.xphs.2023.09.026_bib0013","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijpharm.2012.04.060","article-title":"Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: in vitro and pharmacokinetics studies","volume":"432","author":"Bhatta","year":"2012","journal-title":"Int J Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2023.09.026_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167961","article-title":"Voriconazole composited polyvinyl alcohol\/hydroxypropyl-\u03b2-cyclodextrin nanofibers for ophthalmic delivery","volume":"11","author":"Sun","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.xphs.2023.09.026_bib0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jddst.2018.12.005","article-title":"Improving therapeutic efficacy of voriconazole against fungal keratitis: thermo-sensitive in situ gels as ophthalmic drug carriers","volume":"49","author":"Okur","year":"2019","journal-title":"J Drug Delivery Sci Technol"},{"issue":"1","key":"10.1016\/j.xphs.2023.09.026_bib0016","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/02652048.2015.1128489","article-title":"Novel in situ gelling ocular inserts for voriconazole-loaded niosomes: design, in vitro characterisation and in vivo evaluation of the ocular irritation and drug pharmacokinetics","volume":"33","author":"Shukr","year":"2016","journal-title":"J Microencapsulation"},{"issue":"5-6","key":"10.1016\/j.xphs.2023.09.026_bib0017","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.drudis.2010.12.004","article-title":"Drug delivery to the posterior segment of the eye","volume":"16","author":"Thrimawithana","year":"2011","journal-title":"Drug Discovery Today"},{"issue":"1","key":"10.1016\/j.xphs.2023.09.026_bib0018","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/polym3010193","article-title":"Recent advances in ocular drug delivery systems","volume":"3","author":"Kuno","year":"2011","journal-title":"Polymers"},{"issue":"2","key":"10.1016\/j.xphs.2023.09.026_bib0019","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","article-title":"Ocular drug delivery systems: an overview","volume":"2","author":"Patel","year":"2013","journal-title":"World J Pharmacol"},{"issue":"2","key":"10.1016\/j.xphs.2023.09.026_bib0020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4103\/0975-8453.75042","article-title":"Ophthalmic drug delivery system: challenges and approaches","volume":"1","author":"Patel","year":"2010","journal-title":"Syst Rev Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2023.09.026_bib0021","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/vision7020032","article-title":"Toxic external exposure leading to ocular surface injury","volume":"7","author":"Rauchman","year":"2023","journal-title":"Vision"},{"key":"10.1016\/j.xphs.2023.09.026_bib0022","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2147\/OPTH.S118409","article-title":"Systemic side effects of eye drops: a pharmacokinetic perspective","author":"Farkouh","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"10.1016\/j.xphs.2023.09.026_bib0023","first-page":"270","article-title":"Lacrimal drainage obstruction associated with topical and systemic medications","volume":"4","author":"Pakdel","year":"2009","journal-title":"J Ophthal Vis Res"},{"key":"10.1016\/j.xphs.2023.09.026_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2020.102342","article-title":"Strategies to prolong the residence time of drug delivery systems on ocular surface","volume":"288","author":"Grassiri","year":"2021","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1016\/j.xphs.2023.09.026_bib0025","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1208\/s12249-011-9701-3","article-title":"Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro\/in vivo evaluation","volume":"12","author":"Aburahma","year":"2011","journal-title":"Aaps PharmSciTech"},{"issue":"18","key":"10.1016\/j.xphs.2023.09.026_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/admi.202200211","article-title":"Recent advances in mucoadhesive interface materials, mucoadhesion characterization, and technologies","volume":"9","author":"Bayer","year":"2022","journal-title":"Adv Mater Interfaces"},{"issue":"2","key":"10.1016\/j.xphs.2023.09.026_bib0027","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/2230-973X.100040","article-title":"Ocular insert for sustained delivery of gatifloxacin sesquihydrate: preparation and evaluations","volume":"2","author":"Khurana","year":"2012","journal-title":"Int J Pharmaceut Investig"},{"issue":"1","key":"10.1016\/j.xphs.2023.09.026_bib0028","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/10717544.2010.509364","article-title":"Development and characterization of sponge-like acyclovir ocular minitablets","volume":"18","author":"Refai","year":"2011","journal-title":"Drug Deliv"},{"issue":"2","key":"10.1016\/j.xphs.2023.09.026_bib0029","first-page":"513","article-title":"Freeze-dried xanthan\/guar gum nasal inserts for the delivery of metoclopramide hydrochloride","volume":"11","author":"Dehghan","year":"2012","journal-title":"Iran J Pharmaceut Res: IJPR"},{"key":"10.1016\/j.xphs.2023.09.026_bib0030","first-page":"2013","article-title":"Formulation and evaluation of chitosan-chondroitin sulphate based nasal inserts for zolmitriptan","author":"Kaur","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.xphs.2023.09.026_bib0031","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jddst.2015.11.004","article-title":"Levofloxacin hemihydrate ocular semi-sponges for topical treatment of bacterial conjunctivitis: formulation and in-vitro\/in-vivo characterization","volume":"31","author":"Saher","year":"2016","journal-title":"J Drug Delivery Sci Technol"},{"issue":"4","key":"10.1016\/j.xphs.2023.09.026_bib0032","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3390\/polym10040462","article-title":"Biomedical applications of chitosan and its derivative nanoparticles","volume":"10","author":"Zhao","year":"2018","journal-title":"Polymers"},{"issue":"3","key":"10.1016\/j.xphs.2023.09.026_bib0033","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.carbpol.2005.09.023","article-title":"Water-solubility of chitosan and its antimicrobial activity","volume":"63","author":"Qin","year":"2006","journal-title":"Carbohydr Polym"},{"issue":"7","key":"10.1016\/j.xphs.2023.09.026_bib0034","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.3109\/10717544.2014.987333","article-title":"Preparation and evaluation of nanoparticles loaded ophthalmic in situ gel","volume":"23","author":"Kesarla","year":"2016","journal-title":"Drug Deliv"},{"issue":"1","key":"10.1016\/j.xphs.2023.09.026_bib0035","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1080\/10717544.2018.1477861","article-title":"Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits","volume":"25","author":"Fouda","year":"2018","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2023.09.026_bib0036","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ejps.2018.01.044","article-title":"Enhanced transdermal delivery of ondansetron using nanovesicular systems: fabrication, characterization, optimization and ex-vivo permeation study-Box-Cox transformation practical example","volume":"115","author":"Habib","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.09.026_bib0037","article-title":"Box Behnken optimization of cubosomes for enhancing the anticancer activity of metformin: Design, characterization, and in-vitro cell proliferation assay on MDA-MB-231 breast and LOVO colon cancer cell lines","volume":"X","author":"Zaki","year":"2023","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2023.09.026_bib0038","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3390\/ph15080940","article-title":"Central composite optimization of glycerosomes for the enhanced oral bioavailability and brain delivery of quetiapine fumarate","volume":"15","author":"Zaki","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"11","key":"10.1016\/j.xphs.2023.09.026_bib0039","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.3390\/pharmaceutics14112521","article-title":"Wound healing efficacy of rosuvastatin transethosomal gel, I optimal optimization, histological and in vivo evaluation","volume":"14","author":"Zaki","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.xphs.2023.09.026_bib0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1081\/DDC-120001488","article-title":"Novel use of similarity factors f 2 and S d for the development of diltiazem HCl modified-release tablets using a 32 factorial design","volume":"28","author":"Gohel","year":"2002","journal-title":"Drug Dev Ind Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2023.09.026_bib0041","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/10717540500459308","article-title":"Preparation and characterization of metoprolol controlled-release solid dispersions","volume":"13","author":"Varshosaz","year":"2006","journal-title":"Drug Deliv"},{"issue":"10","key":"10.1016\/j.xphs.2023.09.026_bib0042","first-page":"594","article-title":"Effect of compaction pressure on the dissolution efficiency of some direct compression systems","volume":"47","author":"Khan","year":"1972","journal-title":"Pharm Acta Helv"},{"key":"10.1016\/j.xphs.2023.09.026_bib0043","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1208\/s12249-009-9336-9","article-title":"Design and in vitro evaluation of novel sustained-release double-layer tablets of lornoxicam: utility of cyclodextrin and xanthan gum combination","volume":"10","author":"Hamza","year":"2009","journal-title":"Aaps PharmSciTech"},{"key":"10.1016\/j.xphs.2023.09.026_bib0044","first-page":"2014","article-title":"Evaluation of the DDSolver software applications","author":"Zuo","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.xphs.2023.09.026_bib0045","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","article-title":"DDSolver: an add-in program for modeling and comparison of drug dissolution profiles","volume":"12","author":"Zhang","year":"2010","journal-title":"AAPS J"},{"issue":"2","key":"10.1016\/j.xphs.2023.09.026_bib0046","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0168-3659(03)00130-5","article-title":"Characterization and in vivo evaluation of ocular bioadhesive minitablets compressed at different forces","volume":"89","author":"Weyenberg","year":"2003","journal-title":"J Controlled Release"},{"key":"10.1016\/j.xphs.2023.09.026_bib0047","unstructured":"Bertram U, Bodmeier R. 2006. In situ gelling, bioadhesive nasal inserts for extended drug delivery. ed.: vitro."},{"issue":"1","key":"10.1016\/j.xphs.2023.09.026_bib0048","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/10717544.2017.1365392","article-title":"Transdermal agomelatine microemulsion gel: pyramidal screening, statistical optimization and in vivo bioavailability","volume":"24","author":"Said","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2023.09.026_bib0049","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.colsurfb.2018.06.025","article-title":"A novel concept of overcoming the skin barrier using augmented liquid nanocrystals: Box-Behnken optimization, ex vivo and in vivo evaluation","volume":"170","author":"Said","year":"2018","journal-title":"Colloids Surf B"},{"issue":"1","key":"10.1016\/j.xphs.2023.09.026_bib0050","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10973-011-1299-x","article-title":"Application of DSC, IST, and FTIR study in the compatibility testing of nateglinide with different pharmaceutical excipients","volume":"108","author":"Pani","year":"2012","journal-title":"J Therm Anal Calorim"},{"issue":"3","key":"10.1016\/j.xphs.2023.09.026_bib0051","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/08982104.2013.788025","article-title":"Design and optimization of surfactant-based nanovesicles for ocular delivery of Clotrimazole","volume":"23","author":"Basha","year":"2013","journal-title":"J Liposome Res"},{"key":"10.1016\/j.xphs.2023.09.026_bib0052","first-page":"3791","article-title":"Supercritical fluid-mediated liposomes containing cyclosporin A for the treatment of dry eye syndrome in a rabbit model: comparative study with the conventional cyclosporin A emulsion","author":"Karn","year":"2014","journal-title":"Int J Nanomed"},{"issue":"2","key":"10.1016\/j.xphs.2023.09.026_bib0053","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jconrel.2004.01.025","article-title":"Controlled release of clozapine through chitosan microparticles prepared by a novel method","volume":"96","author":"Agnihotri","year":"2004","journal-title":"J Controlled Release"},{"issue":"1-2","key":"10.1016\/j.xphs.2023.09.026_bib0054","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0378-5173(01)00596-8","article-title":"Polymer particle erosion controlling drug release. I. Factors influencing drug release and characterization of the release mechanism","volume":"217","author":"Zuleger","year":"2001","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2023.09.026_bib0055","first-page":"1","article-title":"Bioadhesive polymers as a platform for drug delivery: possibilities and future trends","volume":"2","author":"Poddar","year":"2010","journal-title":"Res J Pharmaceut Dosage Forms Technol"},{"issue":"5","key":"10.1016\/j.xphs.2023.09.026_bib0056","first-page":"287","article-title":"Mathematical modeling of diffusion controlled drug release profiles from nanoparticles","volume":"6","author":"Yahya","year":"2019","journal-title":"Int J Res Sci Innov (IJRSI)"},{"issue":"3","key":"10.1016\/j.xphs.2023.09.026_bib0057","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264825","article-title":"Comparative statistical analysis of the release kinetics models for nanoprecipitated drug delivery systems based on poly (lactic-co-glycolic acid)","volume":"17","author":"Heredia","year":"2022","journal-title":"PLoS One"},{"issue":"1-2","key":"10.1016\/j.xphs.2023.09.026_bib0058","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0169-409X(93)90025-Y","article-title":"Preparation, structure and diffusional behavior of hydrogels in controlled release","volume":"11","author":"Peppas","year":"1993","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"10.1016\/j.xphs.2023.09.026_bib0059","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1271\/bbb.60.1627","article-title":"Development of a model for analyzing the swelling rate of ionic gels on the basis of the diffusion of mobile ions: application to the pH-sensitive swelling of a polyelectrolyte complex gel prepared from xanthan and chitosan","volume":"60","author":"Chu","year":"1996","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.xphs.2023.09.026_bib0060","series-title":"Physicochemical Aspects of Polymer surfaces","first-page":"143","article-title":"Polymer surface interactions in the biological environment","author":"Wang","year":"1983"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923004070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923004070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:46:28Z","timestamp":1758361588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354923004070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0022354923004070"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2023.09.026","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular Mucoadhesive and Biodegradable Sponge-Like Inserts for the Sustained and Controlled Delivery of Voriconazole; Preparation, D-optimal Factorial Optimization and in-vivo Evaluation","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2023.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of American Pharmacists Association.","name":"copyright","label":"Copyright"}]}}